Detalhe da pesquisa
1.
Cholesterol 24-hydroxylase is a novel pharmacological target for anti-ictogenic and disease modification effects in epilepsy.
Neurobiol Dis
; 173: 105835, 2022 10 15.
Artigo
Inglês
| MEDLINE | ID: mdl-35932989